publication venue for
- Impact of a national dementia research consortium: The Canadian Consortium on Neurodegeneration in Aging (CCNA).. 102:535-561. 2024
- Attitudes and Preferences Towards Screening for Dementia with a Focus on Ethnic Minority and Low Socio-Economic Groups: A Systematic Review of Research Studies Written in the English Language.. 100:1315-1331. 2024
- Prevalence of Potentially Inappropriate Medications in Older Adults with Cognitive Impairment or Dementia Attending Memory Clinics: A Systematic Review and Meta-Analysis.. 101:1107-1120. 2024
- Men Are at Higher Risk of Screening Positive for Vascular Cognitive Impairment Compared to Women after Stroke and Transient Ischemic Attack. 94:89-94. 2023
- Quantitative Lipidomic Analysis of Serum Phospholipids Reveals Dissociable Markers of Alzheimer’s Disease and Subcortical Cerebrovascular Disease. 93:665-682. 2023
- Screening for Cognitive Impairment with the Quick Memory Check: Validation of a Caregiver Administered Cognitive Screen. 90:1417-1427. 2022
- Biomarkers of Prevalent and Incident Cognitive Dysfunction in People with Dysglycemia: Data from the ORIGIN Trial. 87:1143-1150. 2022
- Virtual Reality Experience Intervention May Reduce Responsive Behaviors in Nursing Home Residents with Dementia: A Case Series. 84:883-893. 2021
- Neuroscience20 (BRAIN20, SPINE20, and MENTAL20) Health Initiative: A Global Consortium Addressing the Human and Economic Burden of Brain, Spine, and Mental Disorders Through Neurotech Innovations and Policies. 83:1563-1601. 2021
- Psychometric Properties of EQ-5D-3L and EQ-5D-5L in Cognitively Impaired Patients Living with Dementia. 83:77-87. 2021
- Alzheimer’s Disease and Related Dementia in Indigenous Populations: A Systematic Review of Risk Factors. 78:1439-1451. 2020
- Effect of Wii Fit© Exercise on Balance of Older Adults with Neurocognitive Disorders: A Meta-Analysis. 75:817-826. 2020
- Effects of Aerobic Dance on Cognition in Older Adults with Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. 74:679-690. 2020
- Who Benefits Most from Collaborative Dementia Care from a Patient and Payer Perspective? A Subgroup Cost-Effectiveness Analysis. 74:449-462. 2020
- Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds. 70:S221-S237. 2019
- Effect of Visit-to-Visit Blood Pressure Variability on Cognitive and Functional Decline in Mild to Moderate Alzheimer’s Disease. 68:1499-1510. 2019
- Early Intervention with a Multi-Ingredient Dietary Supplement Improves Mood and Spatial Memory in a Triple Transgenic Mouse Model of Alzheimer’s Disease. 64:835-857. 2018
- Predictors of Delirium Development in Older Medical Inpatients: Readily Identifiable Factors at Admission. 64:775-785. 2018
- Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice. 63:1191-1205. 2018
- 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.. 64:1175-1194. 2018
- Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.. 61:321-332. 2018
- Comparing Approaches to Optimize Cut-off Scores for Short Cognitive Screening Instruments in Mild Cognitive Impairment and Dementia. 57:123-133. 2017
- Physical Exercise Moderates the Relationship of Apolipoprotein E (APOE) Genotype and Dementia Risk: A Population-Based Study. 56:297-303. 2017
- Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.. 56:129-143. 2017
- Connected Language in Late Middle-Aged Adults at Risk for Alzheimer’s Disease. 54:1539-1550. 2016
- A Pilot Study Measuring Aluminum in Bone in Alzheimer’s Disease and control Subjects Using in vivo Neutron Activation Analysis. 53:933-942. 2016
- Excess Costs Associated with Possible Misdiagnosis of Alzheimer’s Disease Among Patients with Vascular Dementia in a UK CPRD Population. 53:171-183. 2016
- Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit. 52:171-178. 2016
- Screening for Mild Cognitive Impairment: Comparison of “MCI Specific” Screening Instruments. 51:619-629. 2016
- A History of In Vivo Neutron Activation Analysis in Measurement of Aluminum in Human Subjects. 50:913-926. 2016
- Renin Angiotensin Aldosterone System Inhibition in Controlling Dementia-Related Cognitive Decline. 42:S575-S586. 2014
- Effects of Centrally Acting Angiotensin Converting Enzyme Inhibitors on Functional Decline in Patients with Alzheimer's Disease. 40:595-603. 2014
- Posttranslational Nitro-Glycative Modifications of Albumin in Alzheimer's Disease: Implications in Cytotoxicity and Amyloid-β Peptide Aggregation. 40:643-657. 2014
- Autoimmune Manifestations in the 3xTg-AD Model of Alzheimer's Disease. 39:191-210. 2014
- In Vitro Amyloid-β Binding and Inhibition of Amyloid-β Self-Association by Therapeutic Albumin. 38:753-765. 2013
- Genetic Determinants of “Cognitive Impairment, No Dementia”. 33:831-840. 2013
- Serial Susceptibility Weighted MRI Measures Brain Iron and Microbleeds in Dementia. 17:599-609. 2009
- A New Function of Human HtrA2 as an Amyloid-β Oligomerization Inhibitor. 17:281-294. 2009
- Alzheimer research forum live discussion: Brain derived neurotrophic factor and Alzheimer's disease – What is the connection?1. 7:173-180. 2005
- Shift from fibrillar to nonfibrillar Aß deposits in the neocortex of subjects with Alzheimer disease. 3:49-57. 2001